PREAPHARM

To guarantee all French-speaking people throughout the world, whatever their nationality, access to French pharmacies to obtain their medicines.

The concept is validated and functional.
The agreement with partners such as pharmacies or transporters are also functional.
Proof of concept and market research completed, validate the need.

Customers : CSP+ with chronic diseases with a need for access to care

Problem :

Inferior or falsified quality : According to the WHO, 50 % of medicines in circulation on the African continent are of inferior quality or falsified, and are thought to have caused the deaths of more than 100,000 people.

Chronic diseases : 25% of the world's sufferers from all diseases are African.

Sourcing : Africa produces less than 2% of the medicines manufactured on the continent, and has a very low density of pharmacies per inhabitant.

Opportunity : Africa is the territory with the most French speakers in the world.
What's more, the image of French medicine and pharmacy in Africa is extremely positive.

Solutions :

Bring French-quality pharmaceutical products at moderate prices, as in France, to patients in Africa and around the world.

No Competitors

Africa is the territory with the most French speakers in the world.
What's more, the image of French medicine and pharmacy in Africa is extremely positive.

Preapharm will be officially launched in the coming months.
The aim of the fund-raising is to process requests (prescriptions) + doctors' training needs, as well as marketing.

Order : The African prescription is scanned by the patient on our application and is automatically transferred using AI to a pharmacy in our network.

Quotation and payement : Within 24 hours, the patient receives the final quote for their order. Payement is made via the protected area of the application.

Delivery : The parcel is prepared by the pharmacy and our partner DHL collects it and delivers it to the address of the patient's choice, with the advantage of having the parcel insured and in less than 8 days.

The requirement is $4,710,000

This will enable us to invest in targeted marketing, and to invest in human resources in the Marseille region, in order to recruit profiles from top schools looking to work for Preapharm.

We offer preapharm shares for investors with resale authorization after 5 years.

Africa is subject to a variety of geopolitical issues, which can occasionally act as a brake.
That's why Preapharm is able to reach the whole world thanks to its international delivery partner.

Currently incubated at Marseille's prestigious Incubateur M

Preapharm has just won the "Provence Africa Connect" prize organized by Emerging Valley on Novembre 2023.
This prize is a validation of the project and its enormous feasibility by major players in Africa.